Medical Options in the Management of Stages 1 and 2 (N0-N3, MO) Testicular Germ Cell Tumors
- 1 November 1987
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 14 (4) , 721-728
- https://doi.org/10.1016/s0094-0143(21)01553-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Limitations to the use of surveillance as an option in the management of stage I seminomaInternational Journal of Andrology, 1987
- Radiotherapy for Stage I seminoma testis: Results of treatment and complicationsRadiotherapy and Oncology, 1986
- Possible New Approaches to the Management of Seminoma of the TestisBritish Journal of Urology, 1984
- Chemotherapy and radiotherapy in advanced testicular non-seminomaRadiotherapy and Oncology, 1984
- Justification of the Use of Surveillance in the Management of Stage I Germ Cell Tumours of the TestisBritish Journal of Urology, 1983
- Evaluation of Radiotherapy and/or Surgicopathological Staging after Chemotherapy in the Management of Metastatic, Germ Cell TumoursBritish Journal of Urology, 1983
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumorsCancer, 1974